<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao C</submitter><funding>Science and Technology Bureau of Jiangning District</funding><pagination>1549</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12354449</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Cuproptosis is a newly defined regulated cell death model and is considered as a potential approach for cancer treatment. We have previously found that cervical cancer cells have the capability of anti-ferroptosis. A recent study has reported that elesclomol (ES) is able to induce copper-dependent ferroptosis. However, its effect on cervical cancer cell ferroptosis is still unclear. In this study, we found that the expression levels of copper metabolism-related genes ATP7A and ATP7B were decreased in cervical cancer tissues. In cervical cancer cells, combined treatment of ES and Cu&lt;sup>2+&lt;/sup> inhibited cell proliferation and promoted cell death, but did not promote cuproptosis. However, ES-Cu&lt;sup>2+&lt;/sup> treatment led to the accumulation of cellular reactive oxygen species, increased ce</pubmed_abstract><journal>Discover oncology</journal><pubmed_title>Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression.</pubmed_title><pmcid>PMC12354449</pmcid><funding_grant_id>2024048S</funding_grant_id><pubmed_authors>Zhao C</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Ju R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression.</name><description>Cuproptosis is a newly defined regulated cell death model and is considered as a potential approach for cancer treatment. We have previously found that cervical cancer cells have the capability of anti-ferroptosis. A recent study has reported that elesclomol (ES) is able to induce copper-dependent ferroptosis. However, its effect on cervical cancer cell ferroptosis is still unclear. In this study, we found that the expression levels of copper metabolism-related genes ATP7A and ATP7B were decreased in cervical cancer tissues. In cervical cancer cells, combined treatment of ES and Cu&lt;sup>2+&lt;/sup> inhibited cell proliferation and promoted cell death, but did not promote cuproptosis. However, ES-Cu&lt;sup>2+&lt;/sup> treatment led to the accumulation of cellular reactive oxygen species, increased ce</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-07-15T06:30:34.316Z</modification><creation>2026-06-30T03:23:06.7Z</creation></dates><accession>S-EPMC12354449</accession><cross_references><pubmed>40810778</pubmed><doi>10.1007/s12672-025-03421-2</doi></cross_references></HashMap>